http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3053202-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 |
filingDate | 2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_246c79227c0225534fe3b97e495b2fa7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab7d0e0d4c78ba0a7e052fa0e9dcd380 |
publicationDate | 2022-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-3053202-C |
titleOfInvention | Crystalline forms of cabotegravir sodium |
abstract | The present invention relates to crystalline forms of cabotegravir sodium and to methods for their preparation. Furthermore, the invention relates to a pharmaceutical composition comprising one of said crystalline forms of cabotegravir sodium, preferably in a predetermined and/or effective amount, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition of the present invention can be used as a medicament, in particular for the treatment and/or prophylaxis of viral infections such as HIV infections. Cabotegravir sodium can be represented by the following chemical structure according to Formula (II): |
priorityDate | 2017-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 164.